HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

BACKGROUND: HER2 and TOP2A parameters (gene status, mRNA and protein expression) have individually been associated with the outcome of patients treated with anthracyclines. The aim of this study was to comprehensively evaluate the prognostic/predictive significance of the above parameters in early,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Fountzilas, George, Valavanis, Christos, Kotoula, Vassiliki, Eleftheraki, Anastasia G, Kalogeras, Konstantine T, Tzaida, Olympia, Batistatou, Anna, Kronenwett, Ralf, Wirtz, Ralph M, Bobos, Mattheos, Timotheadou, Eleni, Soupos, Nikolaos, Pentheroudakis, George, Gogas, Helen, Vlachodimitropoulos, Dimitrios, Polychronidou, Genovefa, Aravantinos, Gerasimos, Koutras, Angelos, Christodoulou, Christos, Pectasides, Dimitrios, Arapantoni, Petroula
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3275536/
https://ncbi.nlm.nih.gov/pubmed/22240029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-10-10
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak